was also made for n-propyl isocyanide, which was suspected, because of its color, to be contaminated with a small amount of n-propyl iodide. The values of the equilibrium constants were averaged, with the concentration of free isocyanide as a weight factor. The equilibrium constants obtained in this way are 2.0 X 105 for ethyl isocyanide, 1.1 X 105 for n-propyl isocyanide, 1.4 X 104 for isopropyl isocyanide, and 1.0 X 103 for t-butyl isocyanide, the units in each case being liters per mole. Most of the investigations in our laboratories having to do directly with cancer and cancer tissues in the last ten years have centered around the development by one of us1' 2 of a convenient method for inoculating and propagating cancer tissue in the yolk sac of embryonated eggs. This method has been developed to a point such that it is now possible to inoculate a series of eggs quantitatively and to harvest several days later a relatively uniform series of egg-grown cancers, along with chick embryos which have grown alongside, utilizing the same blood supply. Each fertile egg will bear a tumor, and without dealing with large numbers it is generally possible to get satisfactory replicate results from different sets of eggs.
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Although there is the expected variation in the sizes of tumors harvested at any given time, this variation is not prohibitively large and does not include zero values. The following results may be regarded as typical. When eggs were inoculated with a suitable tumor suspension on the fourth day of incubation, the tumor weights, expressed in grams, at the end of the tenth day were 0. 19, 0.12, 0.17, 0.08, 0.05, 0.09, and 0.04 . At the end of thirteen days, in a similar set, the respective tumor weights in grams were as follows: 0. 6, 0.9, 0.6, 0.4, 0.3, 0.5, 0.6, and 1.0. This relative uniformity and consistency of growth make it possible to subject various sets of eggs to different treatments and, by comparison with controls, to determine the effects of different treatments both on the cancer growth and on the growth of the chick embryos. Many thousands of experiments involving hundreds of thousands of eggs have been carried out in our laboratories using this technique.
The location of the tumor in the yolk sac is associated with minimum interference with the supporting chick embryo. The chick membranes remain in their normal condition, and compounds being tested for possible anticancer activity can be introduced into the tumor-bearing egg over the membrane blood vessels, analogous to subdermal injection in a free-living animal.3 The embryo serves as a control of rapidly growing nontumor tissue.
It has been noted, both in our laboratories and elsewhere, that serial transplantation of mouse or rat tumors in eggs has adverse effects on individual chick embryos.4 This, if not controlled, will lead to irregular tumor size in the eggs of a particular experiment. There is much variation in the way the individual eggs of a group receiving the same tumor suspension react to the toxic tendency. WVe have eliminated this difficulty by keeping a tumor line going in the host animal. Serial transplants of a tumor in eggs used for our chemotherapy tests are not continued heyond the third generation before resorting again to mouse-grown tumor tissue. With this procedure the tumors are more uniform and grow better, and the tumor-bearing eggs have a higher survival rate.
This tendency for serial transplants of tumor tissue in the egg to become irregularly toxic to the host embryo may have fundamental significance. The phenomenon is very striking in association with certain tumors. In some instances, even after two or three serial egg transplants of a tumor, toxic effects are manifested by an increasing mortality rate in the inoculated eggs. We have cultivated the RC mouse mammary tumor by continuous egg-to-egg transplantation for over ten years. The embryos of many of the eggs are severely affected. The series has been maintained by allowing the tumor-bearing eggs to continue to about the seventeenth day of incubation and then selecting tumor tissue for further trans-.
plants from the eggs which do not manifest the toxic effect. Usually, by the seventeenth day of incubation nearly all the affected embryos are dead. Without such selection the mortality in the inoculated eggs rises rapidly and would soon make it impossible to continue the egg propagation of this tumor.
In our opinion this transfer toxic effect may very well indicate the presence in these tumors of a virus-like tumor agent which changes or mutates in association with the alien egg environment. It is well known that viruses tend to mutate when cultivated under changed conditions. It is noteworthy that the adverse effects observed when a mouse or rat tumor is cultivated continuously in embryonated eggs also extend to the tumor itself. Under such circumstances the tumor growth is inhibited, and its gross appearance is changed.
Much of our egg work for the past several years has been concerned with the extensive testing of various compounds and extracts for their possible anticancer properties. A C3H mouse mammary carcinoma has been the source tumor for the egg inoculations.2 This tumor grows rapidly in eggs, about doubling its size in the 24-hour period from the eleventh to the twelfth day of incubation.
We have been mindful of the limitations as well as of the advantages of this method of study. Much of our investigation has involved a particular tumor. Although our own work on the quantitative distribution of B vitamins in cancers,5
as well as that of others on enzyme content,6' has indicated that tumors induced in different ways and from different sources have much in common, we are fully aware that a specific treatment capable of giving certain results with one tumor may not give duplicate results with another tumor.7' 8 VOL. 42, 19.56 We are also aware that a specific tumor cultivated in embryonated eggs cannot be expected to behave identically with the same tumor grown in its normal host rat or mouse. It is also obvious that the means which might be used to control a cancerous growth in mice or rats could not be carried over unchanged for cancer control in human beings.
Notwithstanding these limitations, the relatively cheaply and easily applied technique that we now have available provides an excellent tool for long-range investigation in cancer control. It would seem that if we are not able to solve the problem of cancer control in eggs, we are less likely to be successful with the more complex system inherent in experimental animals. Although no one can foresee the pathway by which cancer investigation will progress, it seems likely that it may take a course involving, first, the control of cancer in embryonated eggs; second, its control in experimental animals; and, last, its control in human patients.
Our investigations have now reached a point at which we are able to control with substantial success the growth of a particular mouse mammary tumor when it is cultivated in embryonated eggs. In a series of cancer-inoculated eggs 57 out of 58 control embryos had been killed by the sixteenth day of incubation by tumor growth. The remaining one bore a large tumor. In a parallel series of 140 cancerinoculated eggs in which treatment (to be described later) was applied, 86 embryos remained alive on the sixteenth day. Among these, 81 contained mere traces of what may have been viable cancer tissue, but in 5 there were no observable traces. The effects of the cancer inoculation have thus been largely counteracted by the treatment, and we believe that this result merits careful attention. This is particularly true because the treatment used has allowed the chick embryo, sharing one blood stream with the tumor, to grow in a normal manner. We recognize that these results constitute only a beginning. After many years of testing numerous compounds, with dubious results, including many of those which had given some promise in other laboratories, we are encouraged by the progress made.
One of the difficulties in getting able men to work in the cancer field centers is the fact that the ultimate goal seems too far off and progress is not easy to evaluate. Our gleam of success in dealing with a particular cancer-host system (tumorembryonated eggs) which we have selected for study gives us a concrete reason for encouragement.
A number of different agents have been found in various laboratories to be unfavorable to the growth of certain tumors. In most, if not all, instances, the effective compounds are very toxic also to nontumor tissue.8 Our success in controlling an egg-cultivated tumor lies in the simultaneous use of more than one unfavorable influence. Several investigators have tried combinations of different chemical compounds in an effort to discover substances which would act synergistically against tumor growths.9 In our work we have used this approach but have extended it to include not only synergistic chemicals but also the combined effect of chemical and physical agents. Our best success to date has resulted from the combined use of compounds capable of inhibiting tumor growth and a moderate increase in temperature which has previously been found to be, by itself, unfavorable to cancer growth. 10 We have found that the effectiveness of a chemical compound which inhibits tumor growth is increased by raising the temperature of tumor-bearing eggs from the normal 37.20 to 400 C. for hours. For example, aminopterin (4-aminopteroylglutamic acid), which is known to inhibit the growth of some tumors and is also exceedingly toxic to certain nontumor tissues, when injected at a relatively nontoxic dosage over the embryo membrane blood vessels of tumor-bearing eggs incubated for a 24-hour period at the normal 37.20 temperature, inhibited growth of the tumors to the extent that they were 62 per cent as large as those in the control eggs injected with the suspending fluid. At the same time the supporting chick embryos of the experimental eggs were 80 per cent as large as the control embryos. Eggs from this same experiment which were incubated for 24 hours at 400 contained tumors with zero growth (actually a decrease in size) as compared to controls subjected to the same temperature, and the embryos were 102 per cent the size of control embryos. Thus it appears that in association with a raised temperature the aminopterin was more effective against the tumor and less toxic to the embryo (Table 1) . Tables 1 and 2 would continue if the eggs with only the one injection were allowed to continue their incubation for a longer period (Table 3) . Tumor-bearing eggs were injected over the embryonic membranes weith TEM on the tenth day of incubation, and controls were prepared as in the previous experiments. Half the eggs were incubated at 37.20 and half at 400 C. for 48 hours. At the end of this period the eggs incubated at 400 were put back into the 37.20 incubators. Each of these experiments was terminated on the sixteenth day of incubation. At this time there were 5 control eggs alive from the total of 56 used in the 5 experiments of the 37.20 incubated group, and only 1 control egg remained alive from the 40°.37.2°group. On the other hand, 96 of the 136 eggs of the experimental 37.20 group and 86 of the 140 eggs of the experimental 40°-37.2°group survived. When the eggs were autopsied, it was found that the group treated at 37.20 contained normal-appearing tumors which averaged in size 25 per cent-of those contained in the corresponding untreated controls. The control tumor size was based on the average weight of the few remaining alive (associated with live embryos) plus the tumors from the embryos which died before the termination of the experiment. The 40°-37.2°experimental group contained tumors which averaged only 9 per cent of those of the corresponding controls. Further, the slight amount of tumor tissue present in the eggs kept at (1) 37.20 C., (2) higher temperature was generally atypical in appearance, indicating doubtful viability. -It will also be noted in Table 3 that the embryos of the 37.20 experimental group averaged 7.92 gm., whereas the average weight of the embryos of the highertemperature experimental eggs was 9.24 gm. We have no wish to overemphasize the implications of our experiments for cancer therapy. But in a field where any kind of positive result is rare, it does seem that this work warrants some attention-not so much because of any practical accomplishment but rather because of the approach, which could lead to further progress and the establishment of some general principles which apply to cancer control. The yolk sac tumor-bearing egg provides a relatively accessible tumornontumor system, and one which can easily be subjected to a variety of manipu- lations. In addition to the introduction of such variables as chemicals and temperature changes, others, such as X-rays and other types of radiation, can readily he utilized either singly or in combination.
There is a possibility or even a probability that successful cancer treatment will ultimately involve the simultaneous use of more than one type of agent. It may require suitable drugs along with suitable physical agents. Our use of the egg embryo-cancer system has given indication that this is so and should be useful in the further exploration of this possibility.
Summary. It is possible by inoculating tumors into the yolk sac of embryonated eggs to obtain consistent and relatively uniform cancer growths in every fertile egg and to harvest these growths along with the chick embryos which havNe grown alongside, utilizing the same blood stream. With the tumor attached to the inner lining of the yolk sac, test compounds can be injected over the blood vessels of the chick membranes, analogous to subdermal injection.
Using this type of tumor-embryo system, it was discovered that a rise in temperature from the usual incubation temperature of 37.2o-40o C. for a period of 24-48 hours increased the anticancer effects of such compounds as aminopterin and triethylenemelamine. In experiments with TEM plus raised temperature for 48 hours, in which the tumor-bearing eggs received one injection of the compound at the tenth day of incubation, 86 of the group of 140 eggs survived to the sixteenth day of incubation, at which time only traces of atypically appearing tumor were present in most of them. Of 57 controls in the same experiment, all but one were killed by the growing cancers; one survived to the sixteenth day and contained a large tumor.
We The structure for the sodium salt of deoxyribonucleic acid (DNA) proposed by Watson and Crick' requires, in agreement with the more recent analytical data, the occurrence in the molecule of equimolar amounts of adenine and thymine, on the one hand, and of guanine and cytosine, on the other. Since it is by no means certain that all nucleic acids, whether DNA or ribonucleic acid, whatever the source, will conform to this composition, it becomes of interest to inquire into the possibility of other structures which satisfy the chemical evidence concerning the bonding in a single nucleotide chain and which also conform to our knowledge of molecular structures. The basic feature of the Watson-Crick structure is the arrangement of the four bases: these come in the pairs, above, connected by hydrogen bonds which link two polynucleotide chains together, and lie perpendicular to the helical axis of the molecule, 3.4 A apart.
A systematic study of structures which also have the bases perpendicular to a helical axis is described below. Although it may be possible to construct a polynucleotide molecule consisting of a single chain internally linked with hydrogen bonds, it seems reasonable to retain the planar separation of the basis, necessitating two or more nucleotide chains winding about a common helical axis.
We first consider base-base pairs, and, in order to facilitate their description, we number the hydrogen-bonding donor and acceptor sites as follows: 
